ArticleUrologie (Heidelberg, Germany)2024

[Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany].

O Schindler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.